| (19) |
 |
|
(11) |
EP 1 743 889 A8 |
| (12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
Note: Bibliography reflects the latest situation |
| (15) |
Correction information: |
|
Corrected version no 1 (W1 A1) |
| (48) |
Corrigendum issued on: |
|
18.04.2007 Bulletin 2007/16 |
| (43) |
Date of publication: |
|
17.01.2007 Bulletin 2007/03 |
| (22) |
Date of filing: 15.07.2005 |
|
| (51) |
International Patent Classification (IPC):
|
|
| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE
SI SK TR |
|
Designated Extension States: |
|
AL BA HR MK YU |
| (71) |
Applicant: Laboratorios del Dr. Esteve S.A. |
|
08041 Barcelona (ES) |
|
| (72) |
Inventor: |
|
- Cuberes-Altisen, Maria Rosa
San Cugat del Valles,
Barcelona (ES)
|
|
| |
|
| (54) |
Sustituted pyrazoline compounds, having predetermined stereochemistry, for reducing
triglycerides in blood |
(57) The present invention relates to substituted pyrazoline compounds, methods for their
preparation, medicaments comprising these compounds as well as their use for the preparation
of a medicament for the treatment of humans and animal.